Pharma
CMS proposes updates to Medicare drug price negotiation program
The agency released draft guidance for the program that includes Part B drugs and price renegotiations.
Medicare Price Negotiation
Stay updated on Medicare Price Negotiation trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Medicare Price Negotiation's role in Drug Pricing, Access, & Affordability and Pharma.
Pharma
How pharma may be affected by Medicare drug price negotiations
Pharma companies have warned that the lowered prices will mean less drug innovation.
Pharma
CMS unveils the next 15 drugs subject to government price negotiations
And Ozempic is at the top of the list.
Pharma
Medicare price cuts may have unexpected side effects
As the CMS celebrates drug price cuts, experts warn of unintended consequences for consumers and pharmacies.
Pharma
Medicare announces 10 negotiated drug prices
New Medicare price negotiations aim to cut costs on treatments for diabetes, cancer, and more.
Pharma
All 10 drugmakers agree to Medicare drug price negotiations, HHS says
The drugs up for negotiation are some of the most popular and expensive drugs in Medicare.
Pharma
Biden administration unveils 10 Medicare drugs up for price negotiations
The selected drugs span treatments for Type 2 diabetes, Crohn’s disease, cancer, and chronic heart failure.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
